ArticleCureus2026
Three-Dimensionally Printed, On-Demand, Patient-Specific Breast Models to Support Mastectomy Gross Examination: A Proof-of-Concept Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate gross examination of mastectomy specimens relies on accurate correlation between preoperative imaging and specimen anatomy to guide sectioning, orientation, and margin-oriented sampling. Radiologic-pathologic spatial discordance remains a common source of variability, particularly in multifocal tumors and in neoadjuvant-treated specimens with poorly defined tumor beds. Three-dimensional (3D) printing enables the production of patient-specific physical models that may assist in tumor localization and spatial understanding during macroscopic assessment. In this proof-of-concept study, two representative breast magnetic resonance imaging (MRI) examinations were selected from the DUKE-BREAST-CANCER-MRI dataset of The Cancer Imaging Archive (TCIA). The two cases represented unifocal and multifocal breast cancer, respectively. Segmentation of the breast contour and lesions identified as tumors was performed in both cases, with additional segmentation of a possible enlarged axillary lymph node in the second case. Anatomical orientation labels, a nipple landmark, and empty rectangular labels for each case number were incorporated into both models. The projection of the lesions onto the anterior external breast contour was encoded using protruding lines to indicate their relative surface extent. Each model was printed in separate parts, sectioned along the sagittal plane, to indicate the relative position of the tumor(s) in sagittal cross-section. All models were printed using polylactic acid (PLA) filament on a Bambu Lab A1 3D printer (Bambu Lab, Shenzhen, People's Republic of China). Printing time and material use were recorded at the maximal print speed preset of 166%. A Pareto analysis, on printer-estimated total print time and slicer-estimated total material use, was performed on the two-tumor model, with identification of the respective Pareto knees. An additional third model was produced from an MRI examination showing a lesion with associated breast skin thickening and enhancement. This model was printed in two colors to aid the identification of the extent of breast skin with MRI abnormalities. For all three models, a cost estimation was performed, incorporating material use, electricity consumption, and final print weight after support removal for the estimation of incineration cost. In conclusion, MRI-derived, patient-specific 3D-printed breast models may be produced in modest time and at low cost within a pathology-oriented workflow. They may be used not only for spatial orientation but also for educational and research purposes. This proof-of-concept study supports further evaluation of such models as spatial orientation aids for gross sectioning, tumor bed localization, and margin-oriented sampling, particularly in cases with radiologic-pathologic discordance and in neoadjuvant-treated specimens. Future clinical decision support applications would require the development of a validated workflow for model production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.